Correlation between Methicillin-Resistant Staphylococcus aureus Infection with Length of Stay and Mortality at Gunung Jati Regional Hospital, Cirebon, Indonesia: A Case Control Study with Total Sampling
DOI:
https://doi.org/10.35898/ghmj-741116Keywords:
Methicillin-Resistant Staphylococcus aureus (MRSA), Methicillin-Sensitive Staphylococcus aureus (MSSA), Length of Stay, MortalityAbstract
Background: In 2017, WHO identified Methicillin-Resistant Staphylococcus aureus (MRSA) as a high-priority pathogen due to its antimicrobial resistance. MRSA prevalence has been rising since the 1960s, reaching 20% globally and over 80% in some countries. This increasing prevalence of MRSA is accompanied by higher morbidity, more challenging management with difficult treatment, and prolonged length of stay, and consequently increased mortality risk.
Aims: To determine the relationship between MRSA infection with length of stay and mortality at Gunung Jati Regional Hospital, Cirebon, Indonesia.
Methods: A case-control study was performed in 46 cases and 92 controls. This study used total sampling including 138 samples, selected population of MRSA patients between 2021-2023 at Gunung Jati Regional Hospital, Cirebon. Data was taken from medical record and WHONET data.
Results: The Mann-Whitney test results showed a significant correlation between MRSA infection and the length of stay compared to MSSA infection (p=0.003). Furthermore, the Chi-Square test revealed a significant correlation between MRSA infection and mortality (p=0.019; OR, 2.448; 95% CI, 1.151 – 5.205).
Conclusion: Methicillin-Resistant Staphylococcus aureus infection is associated with a longer length of stay and higher mortality compared to Methicillin-Sensitive Staphylococcus aureus infection.
Received: 25 September 2024 | Reviewed: 21 October 2024 |
Revised: 30 November 2024 | Accepted: 15 December 2024.
Downloads
References
Syahniar R, Rayhana, Kharisma DS, Khatami M, Duarsa DBB. Methicillin-resistant staphylococcus aureus among clinical isolates in Indonesia: A systematic review. Vol. 13, Biomedical and Pharmacology Journal. Oriental Scientific Publishing Company; 2020. p. 1871–8. https://doi.org/10.13005/bpj/2062
World Health Organization. WHO updates list of drug-resistant bacteria most threatening to human health [Internet]. 2024 [cited 2024 Sep 4]. Available from: https://www.who.int/news/item/17-05-2024-who-updates-list-of-drug-resistant-bacteria-most-threatening-to-human-health
Perhimpunan Dokter Spesialis Mikrobiologi Klinik Indonesia (PAMKI). Surveilans MRSA di Indonesia Tahun 2022. 2022.
Rodrigues R, Passadouro R, Gomes O, Castro R. Risk factors, length of stay and in-hospital mortality of methicillin-resistant staphylococcus aureus infections: A case-control study. Acta Med Port. 2020;33(3):174–82. https://doi.org/10.20344/amp.10952
Tsuzuki S, Yu J, Matsunaga N, Ohmagari N. Length of stay, hospitalisation costs and in-hospital mortality of methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia in Japan. Public Health. 2021 Sep 1;198:292–6. https://doi.org/10.1016/j.puhe.2021.07.046
Stewart S, Robertson C, Pan J, Kennedy S, Haahr L, Manoukian S, et al. Impact of healthcare-associated infection on length of stay. Journal of Hospital Infection. 2021 Aug 1;114:23–31. https://doi.org/10.1016/j.jhin.2021.02.026
Siddiqui AH, Koirala J. Methicillin-Resistant Staphylococcus aureus. National Library of Medicine. 2023 Apr 2. In: StatPerals [Internet]. Treasure Island (FL): StatPerals Publishing 2024 jan-.PMID: 29489200
Indah Lestari L, Umiana Soleha T, Utami N, Rahmayani Program Studi Pendidikan Dokter F, Kedokteran F, Lampung U, et al. Hubungan Faktor Risiko Dengan Angka Kejadian Infeksi Bakteri Methicillin-Resistant Staphylococcus Aureus (MRSA) Pada Penderita Ulkus. Jurnal Penelitian Perawat Nasional [Internet]. 2022; Available from: http://jurnal.globalhealthsciencegroup.com/index.php/JPPP
Joo EJ, Park DA, Kang CI, Chung DR, Song JH, Lee SM, et al. Reevaluation of the impact of methicillin-resistance on outcomes in patients with staphylococcus aureus bacteremia and endocarditis. Korean Journal of Internal Medicine. 2019 Nov 1;34(6):1347–62. https://doi.org/10.3904/kjim.2017.098
Ali Alghamdi B, Al-Johani I, Al-Shamrani JM, Musamed Alshamrani H, Al-Otaibi BG, Almazmomi K, et al. Antimicrobial resistance in methicillin-resistant staphylococcus aureus. Vol. 30, Saudi Journal of Biological Sciences. Elsevier B.V.; 2023. https://doi.org/10.1016/j.sjbs.2023.103604
Hirabayashi A, Yahara K, Oka K, Kajihara T, Ohkura T, Hosaka Y, et al. Comparison of disease and economic burden between MRSA infection and MRSA colonization in a university hospital: a retrospective data integration study. Antimicrob Resist Infect Control. 2024 Dec 1;13(1). https://doi.org/10.1186/s13756-024-01383-8
Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of Mortality Associated with Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Meta-analysis [Internet]. Vol. 36, Clinical Infectious Diseases. 2003. Available from: https://academic.oup.com/cid/article/36/1/53/283567 https://doi.org/10.1086/345476
Mahjabeen F, Saha U, Mostafa MN, Siddique F, Ahsan E, Fathma S, et al. An Update on Treatment Options for Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: A Systematic Review. Cureus. 2022 Nov 14; https://doi.org/10.7759/cureus.31486
Lade H, Kim JS. Bacterial targets of antibiotics in methicillin-resistant staphylococcus aureus. Antibiotics. 2021 Apr 1;10(4). https://doi.org/10.3390/antibiotics10040398
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2024 Ranidaa' Diyaa' Azmi, dr. Mohammad Erwin Indrakusuma, Sp.MK, dr. Taufan Herwindo Dewangga, Sp.OT

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
GHMJ (Global Health Management Journal) conforms fully to The Budapest Open Access Initiative (BOAI) and DOAJ Open Access Definition. Authors, readers, and reviewers are free to Share ” copy and redistribute the material in any medium or format, and Adapt ” remix, transform, and build upon the material. Author(s) retain unrestricted copyrights and publishing rights of their work. The licensor cannot revoke these freedoms as long as you follow the license terms. Learn the details at the License policy.